BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 36863746)

  • 1. What is the NCD service capacity and disruptions due to COVID-19? Results from the WHO non-communicable disease country capacity survey in the Americas region.
    Luciani S; Caixeta R; Chavez C; Ondarsuhu D; Hennis A
    BMJ Open; 2023 Mar; 13(3):e070085. PubMed ID: 36863746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of the COVID-19 pandemic on service delivery for noncommunicable diseases in the Eastern Mediterranean Region.
    Hammerich A; Fouad H; Elrayah EE; Slama S; El-Awa F; El-Berri H; Abdel Latif N
    East Mediterr Health J; 2022 Jul; 28(7):469-477. PubMed ID: 35959662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capacity of Ugandan public sector health facilities to prevent and control non-communicable diseases: an assessment based upon WHO-PEN standards.
    Rogers HE; Akiteng AR; Mutungi G; Ettinger AS; Schwartz JI
    BMC Health Serv Res; 2018 Aug; 18(1):606. PubMed ID: 30081898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The resiliency of noncommunicable diseases services during the public health crisis: a lesson from Bangkok, Thailand.
    Pitayarangsarit S; Bhagaman N; Yodmai K; Thangsirikul N; Tipayamongkholgul M
    BMC Health Serv Res; 2023 Apr; 23(1):409. PubMed ID: 37101168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-communicable disease (NCD) corners in public sector health facilities in Bangladesh: a qualitative study assessing challenges and opportunities for improving NCD services at the primary healthcare level.
    Rawal LB; Kanda K; Biswas T; Tanim MI; Poudel P; Renzaho AMN; Abdullah AS; Shariful Islam SM; Ahmed SM
    BMJ Open; 2019 Oct; 9(10):e029562. PubMed ID: 31594874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Policies for type 2 diabetes and non-communicable disease management during the COVID-19 pandemic in Kenya and Tanzania: a desk review and views of decision-makers.
    Mohamed SF; Kisia L; Mashiashi I; Mair F; Wisdom JP; Bunn C; Gray C; Kibe PM; Sanya RE; Karugu CH; Mtenga SM; Binyaruka P; Asiki G
    BMJ Open; 2024 Mar; 14(3):e073261. PubMed ID: 38531573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prioritizing noncommunicable diseases in the Americas region in the era of COVID-19.
    Luciani S; Agurto I; Caixeta R; Hennis A
    Rev Panam Salud Publica; 2022; 46():e83. PubMed ID: 35875322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rapid assessment of the impact of coronavirus disease (COVID- 19) pandemic on health care & service delivery for noncommunicable diseases in India.
    Nath A; Sudarshan KL; Rajput GK; Mathew S; Chandrika KRR; Mathur P
    Diabetes Metab Syndr; 2022 Oct; 16(10):102607. PubMed ID: 36115089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human resources challenges in the management of diabetes and hypertension in Mozambique.
    Madede T; Mavume Mangunyane E; Munguambe K; Govo V; Beran D; Levitt N; Damasceno A
    PLoS One; 2024; 19(3):e0297676. PubMed ID: 38551894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access to Medicines for Non-Communicable Diseases (NCDS) during COVID-19 in Kenya: A Descriptive Commentary.
    Kiragu ZW; Gathecha G; Mwangi MK; Ndegwa Z; Pastakia S; Nyagah D; Cizungu RN; Takah Mutwiri M; Ndolo M; Wirtz VJ
    Health Syst Reform; 2021 Jan; 7(1):e1984865. PubMed ID: 34748436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health system adaptions to improve care for people living with non-communicable diseases during COVID-19 in low-middle income countries: A scoping review.
    Baatiema L; Sanuade OA; Allen LN; Abimbola S; Hategeka C; Koram KA; Kruk ME
    J Glob Health; 2023 Mar; 13():06006. PubMed ID: 36862142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How well are non-communicable disease services being integrated into primary health care in Africa: A review of progress against World Health Organization's African regional targets.
    Tesema AG; Ajisegiri WS; Abimbola S; Balane C; Kengne AP; Shiferaw F; Dangou JM; Narasimhan P; Joshi R; Peiris D
    PLoS One; 2020; 15(10):e0240984. PubMed ID: 33091037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparedness of primary health care facilities on implementation of essential non-communicable disease interventions in osun state south-west Nigeria: a rural-urban comparative study.
    Akinwumi AF; Esimai OA; Arije O; Ojo TO; Esan OT
    BMC Health Serv Res; 2023 Feb; 23(1):154. PubMed ID: 36788557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mixed-method study on the provision of remote consultations for non-communicable disease patients during the first wave of the COVID-19 pandemic in Latvia: lessons for the future.
    Kursīte M; Stars I; Strēle I; Gobiņa I; Ķīvīte-Urtāne A; Behmane D; Dūdele A; Villeruša A
    BMC Health Serv Res; 2022 Feb; 22(1):263. PubMed ID: 35219328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring key-stakeholder perceptions on non-communicable disease care during the COVID-19 pandemic in Kenya.
    Sureshkumar S; Mwangi KJ; Gathecha G; Marcus K; Kohlbrenner B; Issom D; Benissa MR; Aebischer-Perone S; Braha N; Candela E; Chhabra KG; Desikachari BR; Dondi A; Etchebehere M; Kengne AP; Missoni E; Mustapha F; Palafox B; Pati S; Madhu PP; Peer N; Quint J; Tabrizi R; Yusoff H; Oris M; Beran DH; Balabanova D; Etter JF
    Pan Afr Med J; 2023; 44():153. PubMed ID: 37455892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-communicable diseases care during COVID-19 pandemic: A mixed-method study in Khurda district of Odisha, India.
    Sahoo KC; Kanungo S; Mahapatra P; Pati S
    Indian J Med Res; 2021 May&Jun; 153(5&6):649-657. PubMed ID: 34380806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Views by health professionals on the responsiveness of commune health stations regarding non-communicable diseases in urban Hanoi, Vietnam: a qualitative study.
    Kien VD; Van Minh H; Giang KB; Ng N; Nguyen V; Tuan LT; Eriksson M
    BMC Health Serv Res; 2018 May; 18(1):392. PubMed ID: 29855320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The capacity of primary healthcare facilities in Bangladesh to prevent and control non-communicable diseases.
    Kabir A; Karim MN; Billah B
    BMC Prim Care; 2023 Mar; 24(1):60. PubMed ID: 36864391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Online Survey of the Perceptions of Clinical and Non-Clinical Professionals on Healthcare for Non-Communicable Diseases and COVID-19 Measures During the Pandemic in Malaysia.
    Sureshkumar S; Mustapha F; Yusoff H; Mwangi KJ; Marcus K; Kohlbrenner B; Issom D; Benissa MR; Aebischer-Perone S; Braha N; Candela E; Chhabra KG; Desikachari BR; Dondi A; Etchebehere M; Gathecha G; Kengne AP; Missoni E; Palafox B; Pati S; Madhu PP; Peer N; Quint J; Tabrizi R; Oris M; Beran D; Balabanova D; Etter JF
    Int J Public Health; 2023; 68():1605861. PubMed ID: 37304500
    [No Abstract]   [Full Text] [Related]  

  • 20. Inequalities in access to new medication delivery services among non-communicable disease patients during the COVID-19 pandemic: findings from nationally representative surveys in Thailand.
    Nontarak J; Vichitkunakorn P; Waleewong O
    Int J Equity Health; 2023 Feb; 22(1):38. PubMed ID: 36849923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.